EGFR and neoplasm: Dercle et al. [87] conducted a study aiming to develop an algorithm predictive of tumor sensitiveness to standard chemotherapy with or without anti-EGFR agents by ML, using data derived from pretreatment and follow-up CT scans for mCRC patients from the CRYSTAL cohort [9].